In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research ...

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

Iovance Biotherapeutics Inc (IOVA) stock saw a decline, ending the day at $6.19 which represents a decrease of $-0.06 or -0.96% from the prior close of $6.25. The stock opened at $6.28 and touched a ...

Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $6.25 which represents a slight increase of $0.06 or 0.97% from the prior close of $6.19. The stock opened at $6.24 and ...

Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Iovance Biotherapeutics (IOVA – Research Report) and ...

Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...

If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the ...

Stifel maintains Buy on Iovance stock with $21 target On Monday, Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to ...

After hours: 7:59:05 p.m. EST ...

At close: January 24 at 4:00:01 p.m. EST ...